GoodRx Holdings Inc. (GDRX) Engagement Falls to 1/3 of 2020 Levels as Omicron Locks Down Recovery - Jefferies

January 5, 2022 8:08 AM EST Send to a Friend
Jefferies analyst Glen Santangelo reiterated a Buy rating and $47.00 price target on GoodRx Holdings Inc. (NASDAQ: GDRX) but sees ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login